Serum sclerostin in acute kidney injury patients

Serum sclerostin in acute kidney injury patients

Background: Many of the mineral metabolite abnormalities encountered in chronic kidney disease (CKD) patients were found also associated with acute kidney injury (AKI). In the last decade, sclerostin was found to intimately affect bone mineral metabolism in CKD patients. Nothing is known about scler...

Full description

Bibliographic Details
Main Authors:	Ahmed Fayed, Dina O. Abdulazim, Mohamed Amin, Samir Elhadidy, Hussien H. Samir, Mona M. Salem, Ibrahim M. Abd ElAzim, Khaled El Sayed El Hawary, Usama A. Sharaf El Din
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Nefrología (English Edition)
Subjects:	AKI Esclerostina FGF23 Septicemia Resistencia a la insulina
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251422000360

Similar Items

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
by: Luciano Artur Lopes Pereira, et al.
Published: (2023-03-01)

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
by: Luciano Artur Lopes Pereira, et al.
Published: (2023-03-01)

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study
by: Ahmed Fayed, et al.
Published: (2023-12-01)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
by: Yinghui Lu, et al.
Published: (2023-04-01)

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients
by: Ahmed Fayed, et al.
Published: (2018-10-01)

Avances en el estudio de los mecanismos involucrados en la modulación de la expresión de esclerostina en células humanas
by: Delgado-Calle J, et al.
Published: (2014-11-01)

The correlation between sclerostin and bone mineral density in renal transplant recipients
by: Melahat Coban, et al.
Published: (2020-09-01)

The correlation between sclerostin and bone mineral density in renal transplant recipients
by: Melahat Coban, et al.
Published: (2020-09-01)

Diagnostic accuracy of urinary neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury
by: Patel ML, et al.
Published: (2016-07-01)

Estudio funcional de los polimorfismos del promotor del gen de la esclerostina
by: Pérez-Campo FM, et al.
Published: (2016-11-01)

Esclerostina y Dkk-1 séricos en pacientes que inician tratamiento con glucocorticoides. Resultados preliminares
by: Gifre L, et al.
Published: (2013-11-01)

Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
by: Cheng Q, et al.
Published: (2018-11-01)

Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review
by: Usama A.A. Sharaf El Din, et al.
Published: (2017-05-01)

Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin
by: Helen J. Knowles, et al.
Published: (2023-05-01)

Variables que influyen en las concentraciones de esclerostina en los pacientes con diabetes mellitus tipo 2 y su asociación con el metabolismo óseo
by: García-Martín A, et al.
Published: (2012-11-01)

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
by: Monika Sykała, et al.
Published: (2021-07-01)

The Effect of a Comprehensive Life-Style Intervention Program of Diet and Exercise on Four Bone-Derived Proteins, FGF-23, Osteopontin, NGAL and Sclerostin, in Overweight or Obese Children and Adolescents
by: Sofia I. Karampatsou, et al.
Published: (2022-09-01)

Papel del Romosozumab en la práctica clínica a la luz de la evidencia
by: Alejandro Román-González, et al.
Published: (2022-01-01)

Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01)

Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-α
by: SAMIRA SALEH, et al.
Published: (2014-12-01)

Diabetes mellitus tipo 2 y resistencia a la insulina
by: Enrique Cipriani-Thorne, et al.
Published: (2010-07-01)

Fibroblast growth factor-23 and hypophosphatemia in chronic obstructive pulmonary disease patients
by: Elsammak Mohamed Y., et al.
Published: (2012-01-01)

Insulin and Alzheimer disease: type 3 diabetes?
by: Andrés Jagua Gualdrón, et al.
Published: (2007-01-01)

Diferente evolución de la esclerostina sérica respecto de otros marcadores de remodelado óseo en el primer año tras un trasplante hepático
by: Martín González A, et al.
Published: (2019-03-01)

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
by: Usama Abdel Azim Sharaf El Din, et al.
Published: (2022-07-01)

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
by: Usama Abdel Azim Sharaf El Din, et al.
Published: (2022-07-01)

Efeitos do exercicio físico em parâmetros moleculares da via de sinalização da insulina e obesidade
by: Joni Marcio de Farias
Published: (2014-08-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2022-12-01)

Assessment of fibroblast growth factor 23 in relation to peripheral arterial disease in type 2 diabetes mellitus
by: Mohamed R Halawa, et al.
Published: (2019-01-01)

Factores determinantes de la respuesta insulínica en sujetos con pruebas normales de tolerancia oral a la glucosa
by: Jaime Villeno Chávez, et al.
Published: (2001-03-01)

Asociación entre niveles de testosterona, sensibilidad a la insulina, adiposidad y parámetros lipídicos en hombres
by: Aimée Álvarez Álvarez, et al.

Bacteremia and conventional diagnosis of Sphingobacterium spiritivorum. A case report
by: Elio Jesús Núñez Tamayo, et al.
Published: (2003-12-01)

Bacteremia and conventional diagnosis of Sphingobacterium spiritivorum. A case report
by: Elio Jesús Núñez Tamayo, et al.
Published: (2003-12-01)

Effect of lipohypertrophy on the metabolic control of patients with type 2 diabetes mellitus
by: Cynthia Ortiz-Roa, et al.
Published: (2017-10-01)

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
by: Andreja Figurek, et al.
Published: (2021-05-01)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
by: L Yu Milovanova, et al.
Published: (2018-06-01)

Adiposidad, resistencia a la insulina y dislipidemia
by: Angélica María Serrano Cruz
Published: (2011-10-01)

Asociación entre el incremento de la circunferencia abdominal y dislipidemia secundaria o resistencia a la insulina en adolescentes obesos
by: Dustin Oswaldo Nuñez García
Published: (2022-09-01)

Resistência à insulina em adolescentes com e sem excesso de peso de município da Grande Florianópolis-SC
by: Fabia Rosa Sigwalt, et al.
Published: (2014-01-01)